Multidimensional analyses of the pathomechanism caused by the non-catalytic GNE variant, c.620A>T, in patients with GNE myopathy

[1]  S. Ovchinnikov,et al.  ColabFold: making protein folding accessible to all , 2022, Nature Methods.

[2]  Kyuto Sonehara,et al.  Obelisc: an identical-by-descent mapping tool based on SNP streak , 2020, Bioinform..

[3]  Robert D. Finn,et al.  MGnify: the microbiome analysis resource in 2020 , 2019, Nucleic Acids Res..

[4]  W. Gahl,et al.  Open-Label Phase 2 Clinical Trial of ManNAc for GNE Myopathy (S23.008) , 2019 .

[5]  I. Nishino,et al.  GNE genotype explains 20% of phenotypic variability in GNE myopathy , 2019, Neurology: Genetics.

[6]  M. Tarnopolsky,et al.  A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy , 2019, Neurology.

[7]  I. Nishino,et al.  GNE myopathy in Chinese population: hotspot and novel mutations , 2018, Journal of Human Genetics.

[8]  M Mirdita,et al.  MMseqs2 desktop and local web server app for fast, interactive sequence searches , 2018, bioRxiv.

[9]  I. Nishino,et al.  Phenotypic stratification and genotype–phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: First report from the GNE myopathy Disease Monitoring Program, registry portion , 2017, Neuromuscular Disorders.

[10]  I. Nonaka,et al.  Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy , 2017, Human molecular genetics.

[11]  Vijay S. Pande,et al.  OpenMM 7: Rapid development of high performance algorithms for molecular dynamics , 2016, bioRxiv.

[12]  Maria Jesus Martin,et al.  Uniclust databases of clustered and deeply annotated protein sequences and alignments , 2016, Nucleic Acids Res..

[13]  I. Nishino,et al.  Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5′UTR and founder allele , 2016, Journal of Human Genetics.

[14]  Chi-Hung Huang,et al.  Mechanism and inhibition of human UDP-GlcNAc 2-epimerase, the key enzyme in sialic acid biosynthesis , 2016, Scientific Reports.

[15]  K. Okamura,et al.  Human genetic variation database, a reference database of genetic variations in the Japanese population , 2016, Journal of Human Genetics.

[16]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[17]  S. Salzberg,et al.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.

[18]  T. Ogata,et al.  Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an ‘exome-first’ approach , 2015, Journal of Human Genetics.

[19]  N. Yonemoto,et al.  Nationwide patient registry for GNE myopathy in Japan , 2014, Orphanet Journal of Rare Diseases.

[20]  I. Nonaka,et al.  Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice. , 2014, Brain : a journal of neurology.

[21]  W. Gahl,et al.  Mutation Update for GNE Gene Variants Associated with GNE Myopathy , 2014, Human mutation.

[22]  I. Nishino,et al.  GNE myopathy: current update and future therapy , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  Joshua C. Denny,et al.  Integration of Sequence Data from a Consanguineous Family with Genetic Data from an Outbred Population Identifies PLB1 as a Candidate Rheumatoid Arthritis Risk Gene , 2014, PloS one.

[24]  I. Nonaka,et al.  Mutation profile of the GNE gene in Japanese patients with distal myopathy with rimmed vacuoles (GNE myopathy) , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  Y. Hayashi,et al.  Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy) , 2013, Orphanet Journal of Rare Diseases.

[26]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[27]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[28]  E. Wang,et al.  Analysis and design of RNA sequencing experiments for identifying isoform regulation , 2010, Nature Methods.

[29]  I. Nonaka,et al.  Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model , 2009, Nature Medicine.

[30]  Y. Hayashi,et al.  Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV/hIBM. , 2008, Physiological genomics.

[31]  R. Horstkorte,et al.  Reduced sialylation status in UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE)-deficient mice , 2007, Glycoconjugate Journal.

[32]  I. Nonaka,et al.  A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. , 2007, Human molecular genetics.

[33]  K. Yarema,et al.  No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation. , 2005, Biochemical and biophysical research communications.

[34]  I. Nonaka,et al.  Reduction of UDP-N-acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase Activity and Sialylation in Distal Myopathy with Rimmed Vacuoles* , 2004, Journal of Biological Chemistry.

[35]  S. Mitrani‐Rosenbaum,et al.  Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy , 2003, Neurology.

[36]  Tsviya Olender,et al.  The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy , 2001, Nature Genetics.

[37]  H. Ogura,et al.  Determination of mono-O-acetylated N-acetylneuraminic acids in human and rat sera by fluorometric high-performance liquid chromatography. , 1989, Analytical biochemistry.

[38]  P. Majumder,et al.  Mutation Spectrum of GNE Myopathy in the Indian Sub-Continent. , 2018, Journal of neuromuscular diseases.